Avadel Net Income from 2010 to 2024

AVDL Stock  USD 17.97  0.16  0.90%   
Avadel Pharmaceuticals Net Loss yearly trend continues to be quite stable with very little volatility. Net Loss may rise above about -152.3 M this year. From the period between 2010 and 2024, Avadel Pharmaceuticals, Net Loss regression line of its data series had standard deviation of  68,467,173 and standard deviation of  68,467,173. View All Fundamentals
 
Net Loss  
First Reported
1996-03-31
Previous Quarter
-36.3 M
Current Value
-28.8 M
Quarterly Volatility
16.8 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Avadel Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avadel main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 M, Interest Expense of 10.4 M or Selling General Administrative of 159.3 M, as well as many exotic indicators such as Price To Sales Ratio of 38.26, Dividend Yield of 0.0 or PTB Ratio of 13.55. Avadel financial statements analysis is a perfect complement when working with Avadel Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Avadel Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Avadel Pharmaceuticals Technical models . Check out the analysis of Avadel Pharmaceuticals Correlation against competitors.

Latest Avadel Pharmaceuticals' Net Income Growth Pattern

Below is the plot of the Net Income of Avadel Pharmaceuticals PLC over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Avadel Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Avadel Pharmaceuticals PLC operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Avadel Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avadel Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (160.28 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Avadel Net Income Regression Statistics

Arithmetic Mean(48,595,280)
Geometric Mean37,824,595
Coefficient Of Variation(140.89)
Mean Deviation55,462,603
Median(41,276,000)
Standard Deviation68,467,173
Sample Variance4687.8T
Range227.5M
R-Value(0.62)
Mean Square Error3102.5T
R-Squared0.39
Significance0.01
Slope(9,504,784)
Total Sum of Squares65628.6T

Avadel Net Income History

2024-152.3 M
2023-160.3 M
2022-137.5 M
2021-77.3 M
2020M
2019-33.2 M
2018-95.3 M

Other Fundumenentals of Avadel Pharmaceuticals

Avadel Pharmaceuticals Net Income component correlations

About Avadel Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Avadel Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Avadel Pharmaceuticals investors use historical funamental indicators, such as Avadel Pharmaceuticals's Net Income, to determine how well the company is positioned to perform in the future. Although Avadel Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Avadel Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Avadel Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Avadel Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Avadel Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-160.3 M-152.3 M
Net Loss-123.7 M-117.5 M
Net Loss-160.3 M-152.3 M
Net Loss(2.00)(1.90)
Net Income Per E B T 1.00  1.08 

Pair Trading with Avadel Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avadel Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avadel Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Avadel Stock

  0.64CGC Canopy Growth Corp Downward RallyPairCorr

Moving against Avadel Stock

  0.73MCD McDonalds Financial Report 25th of July 2024 PairCorr
  0.61INTC Intel Financial Report 25th of July 2024 PairCorr
  0.42PFE Pfizer Inc Earnings Call TomorrowPairCorr
The ability to find closely correlated positions to Avadel Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avadel Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avadel Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avadel Pharmaceuticals PLC to buy it.
The correlation of Avadel Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avadel Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avadel Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avadel Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Avadel Pharmaceuticals is a strong investment it is important to analyze Avadel Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avadel Pharmaceuticals' future performance. For an informed investment choice regarding Avadel Stock, refer to the following important reports:
Check out the analysis of Avadel Pharmaceuticals Correlation against competitors.
Note that the Avadel Pharmaceuticals information on this page should be used as a complementary analysis to other Avadel Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Avadel Stock analysis

When running Avadel Pharmaceuticals' price analysis, check to measure Avadel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avadel Pharmaceuticals is operating at the current time. Most of Avadel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Avadel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avadel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Avadel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Transaction History
View history of all your transactions and understand their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Is Avadel Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.00)
Revenue Per Share
0.349
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.58)
Return On Equity
(4.81)
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.